Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs RVTY✓SelectedUSD · RVTYGSK vs RVTY performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs RVTY

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+97.1%
RVTY return
+198.4%
Excess return
-101.4%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioRVTYExcessAlpha
1D-0.1%-4.2%+4.1%+0.6%
7D-5.3%-5.9%+0.6%-4.3%
30D-3.7%-7.2%+3.6%-2.6%
3M-7.3%+17.0%-24.3%-10.5%
6M-4.2%+53.3%-57.6%-12.5%
YTD+0.9%+50.5%-49.6%-8.2%
1Y+7.3%+54.8%-47.6%-3.0%
3Y+52.7%+66.1%-13.4%+33.6%
5Y+40.1%-22.2%+62.3%+41.4%
All+97.1%+198.4%-101.4%+39.9%

Cumulative growth

Daily Returns

Daily percentage return beside RVTY.

Daily Out/Under-Performance

Portfolio return minus RVTY return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × RVTY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded RVTY wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling